miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1

door Butz, Henriett, Szabó, Peter M., Khella, Heba W.Z., Nofech-Mozes, Roy, Patocs, Attila, Yousef, George M.
Gepubliceerd in Oncotarget (2015)

MicroRNA‐194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma

door Nofech‐Mozes, Roy, Khella, Heba W. Z., Scorilas, Andreas, Youssef, Leza, Krylov, Sergey N., Lianidou, Evi, Sidiropoulos, Konstantinos G., Gabril, Manal, Evans, Andrew, Yousef, George M
Gepubliceerd in Cancer Med (2016)

miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma

door Khella, Heba W Z, Butz, Henriett, Ding, Qiang, Rotondo, Fabio, Evans, Kenneth R, Kupchak, Peter, Dharsee, Moyez, Latif, Ashraf, Pasic, Maria D, Lianidou, Evi, Bjarnason, Georg A, Yousef, George M
Gepubliceerd in Mol Ther (2015)

Therapeutic targeting of TFE3/IRS-1/PI3K/mTOR axis in translocation renal cell carcinoma

door Damayanti, Nur P., Budka, Justin A., Khella, Heba W.Z, Ferris, Mary W., Ku, Sheng Yu, Kauffman, Eric, Wood, Anthony C., Ahmed, Khunsha, Chintala, Venkata Nithinsai, Adelaiye-Ogala, Remi, Elbanna, May, Orillion, Ashley, Chintala, Sreenivasulu, Kao, Chinghai, Linehan, W. Marston, Yousef, George M, Hollenhorst, Peter C., Pili, Roberto
Gepubliceerd in Clin Cancer Res (2018)